Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc. reports developments in population health management, value-based primary care and physician-led care coordination. The company supports community providers through administrative services, clinical operations, data-driven care enablement and partnerships tied to Medicare Advantage, accountable care organizations and delegated-risk arrangements.
Recurring updates include quarterly results, guidance, revenue trends, capitated revenue per member, medical margin, adjusted EBITDA and operating changes in the Care Enablement Model. Company news also covers payer and provider agreements, ACO management services, market expansion, investor conference participation and joint venture activity such as the P3 Commonwealth Innovation MSO.
P3 Health Partners (NASDAQ: PIII), a population health management company, announced its participation in upcoming investor conferences. These include the William Blair 44th Annual Growth Stock Conference in Chicago, IL on June 4, 2024, where P3 will present at 12:20 pm Eastern Time, and the Jefferies Healthcare Conference in Miami Beach, FL on June 6, 2024, with a presentation at 11:00 am Eastern Time.
Both presentations will be webcast live on P3's investor relations website, with replays available for 90 days following the events.
P3 Health Partners announced a definitive agreement for a $42.2 million private placement with institutional investors, led by affiliates of Chicago Pacific Founders (CPF). The company will issue approximately 67.4 million units at $0.6270 per unit, each including one share of Class A common stock and a warrant to buy another share at $0.5020. Net proceeds will be used for working capital and general corporate purposes. Closing is expected around May 24, 2024, subject to conditions. William Blair & Company served as the sole placement agent.
P3 Health Partners Inc. (NASDAQ: PIII) reported the approval of employment inducement equity grants to Aric Coffman, M.D., who will serve as the Chief Executive Officer and President. The grants include a stock option for 12,100,000 Class A shares of Common Stock and a restricted stock unit (RSU) award for 4,400,000 shares of Common Stock. Both awards are subject to vesting conditions based on Dr. Coffman's employment and the company's performance.
P3 Health Partners Inc. announced that Dr. Aric Coffman has been appointed as the new CEO, effective May 8, 2024, succeeding Dr. Sherif Abdou. Dr. Abdou will continue as a Strategic Advisor and Board member. Dr. Coffman brings extensive experience in value-based care and healthcare delivery for seniors, with a successful track record in leadership roles. The appointment reflects the company's focus on growth and success in the value-based care sector.
P3 Health Partners announced its first quarter 2024 results, showcasing a 29% year-over-year revenue growth. Dr. Aric Coffman joined as CEO, with a focus on achieving profitability in 2024. The company reaffirmed its 2024 guidance, aiming for Adjusted EBITDA positivity. Total revenue was $388.5 million, capitated revenue saw a significant increase, but gross profit saw a decline. The net loss improved slightly, while Adjusted EBITDA loss also increased. Fiscal 2024 guidance outlines ambitious targets for at-risk members, total revenues, medical margin, and Adjusted EBITDA.
P3 Health Partners Inc. (NASDAQ: PIII) announced the schedule for its first quarter 2024 earnings release and conference call. The financial results will be released on May 8, 2024, followed by a conference call to discuss the results at 1:30pm PT/ 4:30pm ET on the same day.
Summary not available.
Summary not available.
Summary not available.
Summary not available.